Gense Technologies
PrivateLast Round
Pre Seed
Nov 15, 2023
Total Funding Raised
$3.68M
Company Overview
Gense Technologies operates in Healthcare & Life Sciences and is based in Hong Kong. Its latest recorded funding round was a Pre Seed round in November 2023.
Gense Technologies is a healthcare company that develops a portable AI-powered medical diagnostic screening device for preventative screening and chronic disease monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gense Technologies Comparables
Compare Gense Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eieling Technology Limited | 81% | |
| Vave Health | 71% | |
| Sonic Incytes Medical Corp. | 68% |
For institutional investors. Book with your work email.
Gense Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Nov 15, 2023 | ||||
| VC Round | Dec 13, 2022 | ||||
| Grant | Apr 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gense Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gobi Partners | Seed, Pre Seed, VC Round |
| ParticleX | Pre Seed, Seed |
| Cyberport Hong Kong | Pre Seed, Seed, VC Round, Grant |
| Cyberport Incubation Programme | Accelerator |
| The Hong Kong University of Science and Technology | Seed |
| Hong Kong Science and Technology Parks Corporation | Grant |
| Innovation and Technology Commission | Pre Seed, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 80% MoM.
- Jul 18, 2025
Grew 29% QoQ, from 14 to 18 employees.
For institutional investors. Book with your work email.
Gense Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gense Technologies's valuation, stock price, and market status.
Is Gense Technologies a public or private company?
Gense Technologies is a private company.
What is the current stock price of Gense Technologies?
Gense Technologies is a private company, so its shares have no public market price. Caplight tracks Gense Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gense Technologies worth (valuation)?
Valuation information for Gense Technologies is not publicly available.
Can I buy Gense Technologies stock?
Gense Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gense Technologies's last funding round?
Gense Technologies's most recent funding round was Pre Seed on November 15, 2023.
Who are the main investors in Gense Technologies?
Key investors in Gense Technologies include Gobi Partners.
Will Gense Technologies IPO soon?
No public IPO plans have been announced for Gense Technologies.
How can I track Gense Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Gense Technologies's shares on secondary markets.